BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 15961945)

  • 1. Preliminary evidence for ethnic differences in primary hyperoxaluria type 1 genotype.
    Coulter-Mackie MB
    Am J Nephrol; 2005; 25(3):264-8. PubMed ID: 15961945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive mutation screening in 55 probands with type 1 primary hyperoxaluria shows feasibility of a gene-based diagnosis.
    Monico CG; Rossetti S; Schwanz HA; Olson JB; Lundquist PA; Dawson DB; Harris PC; Milliner DS
    J Am Soc Nephrol; 2007 Jun; 18(6):1905-14. PubMed ID: 17460142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The major allele of the alanine:glyoxylate aminotransferase gene: nine novel mutations and polymorphisms associated with primary hyperoxaluria type 1.
    Coulter-Mackie MB; Lian Q; Applegarth D; Toone J
    Mol Genet Metab; 2005; 86(1-2):172-8. PubMed ID: 15963748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum of primary hyperoxaluria type 1 in Tunisia: implication for diagnosis in North Africa.
    Nagara M; Tiar A; Ben Halim N; Ben Rhouma F; Messaoud O; Bouyacoub Y; Kefi R; Hassayoun S; Zouari N; Ben Ammar MS; Abdelhak S; Chemli J
    Gene; 2013 Sep; 527(1):316-20. PubMed ID: 23810941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Primary hyperoxaluria type 1 in the Canary Islands: a conformational disease due to I244T mutation in the P11L-containing alanine:glyoxylate aminotransferase.
    Santana A; Salido E; Torres A; Shapiro LJ
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7277-82. PubMed ID: 12777626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The molecular basis of alanine: glyoxylate aminotransferase mistargeting: the most common single cause of primary hyperoxaluria type 1.
    Danpure CJ
    J Nephrol; 1998; 11 Suppl 1():8-12. PubMed ID: 9604801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary hyperoxaluria type 1: update and additional mutation analysis of the AGXT gene.
    Williams EL; Acquaviva C; Amoroso A; Chevalier F; Coulter-Mackie M; Monico CG; Giachino D; Owen T; Robbiano A; Salido E; Waterham H; Rumsby G
    Hum Mutat; 2009 Jun; 30(6):910-7. PubMed ID: 19479957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic heterogeneity in primary hyperoxaluria type 1: impact on diagnosis.
    Coulter-Mackie MB; Rumsby G
    Mol Genet Metab; 2004; 83(1-2):38-46. PubMed ID: 15464418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The major allele of the alanine:glyoxylate aminotransferase gene: seven novel mutations causing primary hyperoxaluria type 1.
    Coulter-Mackie MB; Applegarth D; Toone JR; Henderson H
    Mol Genet Metab; 2004 May; 82(1):64-8. PubMed ID: 15110324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four of the most common mutations in primary hyperoxaluria type 1 unmask the cryptic mitochondrial targeting sequence of alanine:glyoxylate aminotransferase encoded by the polymorphic minor allele.
    Fargue S; Lewin J; Rumsby G; Danpure CJ
    J Biol Chem; 2013 Jan; 288(4):2475-84. PubMed ID: 23229545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of new mutations in primary hyperoxaluria type 1 (PH1).
    von Schnakenburg C; Rumsby G
    J Nephrol; 1998; 11 Suppl 1():15-7. PubMed ID: 9604803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional synergism between the most common polymorphism in human alanine:glyoxylate aminotransferase and four of the most common disease-causing mutations.
    Lumb MJ; Danpure CJ
    J Biol Chem; 2000 Nov; 275(46):36415-22. PubMed ID: 10960483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutation-based diagnostic testing for primary hyperoxaluria type 1: survey of results.
    Coulter-Mackie MB; Lian Q; Applegarth DA; Toone J; Waters PJ; Vallance H
    Clin Biochem; 2008 May; 41(7-8):598-602. PubMed ID: 18282470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Three novel deletions in the alanine:glyoxylate aminotransferase gene of three patients with type 1 hyperoxaluria.
    Coulter-Mackie MB; Rumsby G; Applegarth DA; Toone JR
    Mol Genet Metab; 2001 Nov; 74(3):314-21. PubMed ID: 11708860
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of human alanine:glyoxylate aminotransferase in Escherichia coli: renaturation from guanidine-HCl and affinity for pyridoxal phosphate co-factor.
    Coulter-Mackie MB; Lian Q; Wong SG
    Protein Expr Purif; 2005 May; 41(1):18-26. PubMed ID: 15802217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyridoxamine and pyridoxal are more effective than pyridoxine in rescuing folding-defective variants of human alanine:glyoxylate aminotransferase causing primary hyperoxaluria type I.
    Oppici E; Fargue S; Reid ES; Mills PB; Clayton PT; Danpure CJ; Cellini B
    Hum Mol Genet; 2015 Oct; 24(19):5500-11. PubMed ID: 26199318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [From gene to disease; primary hyperoxaluria type I caused by mutations in the AGXT gene].
    van Woerden CS; Groothof JW; Wanders RJ; Waterham HR; Wijburg FR
    Ned Tijdschr Geneeskd; 2006 Jul; 150(30):1669-72. PubMed ID: 16922352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A double mutation in AGXT gene in families with primary hyperoxaluria type 1.
    Kanoun H; Jarraya F; Hadj Salem I; Mahfoudh H; Chaabouni Y; Makni F; Hachicha J; Fakhfakh F
    Gene; 2013 Dec; 531(2):451-6. PubMed ID: 24012869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Partial deletion of the AGXT gene (EX1_EX7del): A new genotype in hyperoxaluria type 1.
    Nogueira PK; Vuong TS; Bouton O; Maillard A; Marchand M; Rolland MO; Cochat P; Bozon D
    Hum Mutat; 2000 Apr; 15(4):384-5. PubMed ID: 10737993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary hyperoxaluria type 1: genotypic and phenotypic heterogeneity.
    Danpure CJ; Jennings PR; Fryer P; Purdue PE; Allsop J
    J Inherit Metab Dis; 1994; 17(4):487-99. PubMed ID: 7967498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.